Try our Advanced Search for more refined results

Expert Analysis

What FTC Is Saying In 1st Post-Actavis Pay-For-Delay Case

Law360, New York (September 11, 2014, 12:13 PM EDT) -- On Sept. 8, 2014, the Federal Trade Commission filed a federal antitrust complaint in the United States District Court for the Eastern District of Pennsylvania against defendants AbbVie Inc., Abbott Laboratories Inc., Unimed Pharmaceuticals LLC, Besins Healthcare Inc. and Teva Pharmaceuticals Industries Inc. alleging violations of Section 5 of the FTC Act, 15 U.S.C. § 45(a), for entering into an agreement to maintain a monopoly over and restrain generic competition to AndroGel, a testosterone replacement therapy product....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!